SCHEMBL14520180

SCHEMBL14520180

COc1cc(CNC(=O)CNC(=N)N)ccc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.59
CYP3A4 P08684 5/20 0.59
CYP2D6 P10635 4/20 0.59
ALDH1A1 P00352 4/20 0.59
CYP2C9 P11712 3/20 0.59
CYP2C19 P33261 3/20 0.59
HPGD P15428 3/20 0.59
BLM P54132 2/20 0.59
PMP22 Q01453 2/20 0.59
ALOX15 P16050 2/20 0.59
TRPV1 Q8NER1 8/20 0.58
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
POLB P06746 1/20 0.56
TSHR P16473 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
MAPT P10636 3/20 0.56
TP53 P04637 2/20 0.56
KDM1A O60341 1/20 0.56
NR1I2 O75469 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599665 0.88 TAAR1 (0.57) CYP1A2CYP3A4CYP2D6ALDH1A1CYP2C9
SCHEMBL4208734 0.82 ALDH1A1 (0.62) CYP1A2CYP3A4CYP2D6ALDH1A1CYP2C9
SCHEMBL17205705 0.81 CYP1A2 (0.71) CYP1A2CYP3A4CYP2D6ALDH1A1CYP2C9
SCHEMBL8168115 0.81 ALDH1A1 (0.67) CYP1A2CYP3A4CYP2D6ALDH1A1CYP2C9
SCHEMBL24092698 0.80 CYP1A2 (0.66) CYP1A2CYP3A4CYP2D6ALDH1A1CYP2C9
SCHEMBL7932225 0.80 CYP1A2 (0.66) CYP1A2CYP3A4CYP2D6ALDH1A1CYP2C9
SCHEMBL28464370 0.80 ALDH1A1 (0.59) CYP1A2CYP3A4CYP2D6ALDH1A1CYP2C9
SCHEMBL6409250 0.80 CYP1A2 (0.81) CYP1A2CYP3A4CYP2D6ALDH1A1CYP2C9
SCHEMBL906527 0.79 CYP1A2 (0.81) CYP1A2CYP3A4CYP2D6ALDH1A1CYP2C9
SCHEMBL5348698 0.79 CYP1A2 (0.90) CYP1A2CYP3A4CYP2D6ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070082918-A1 NEUROLOGICALLY ACTIVE COMPOUNDS AND COMPOUNDS WITH MULTIPLE ACTIVITIES NAFTCHI N E 2007-04-12 US disclosed
US-20070082918-A1 NEUROLOGICALLY ACTIVE COMPOUNDS AND COMPOUNDS WITH MULTIPLE ACTIVITIES NAFTCHI N E 2007-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082918-A1 NEUROLOGICALLY ACTIVE COMPOUNDS AND COMPOUNDS WITH MULTIPLE ACTIVITIES ADRB2, ADRB1, CHRNA7 CYP1A2 552/4885CYP3A4 658/4885CYP2D6 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.